Results 91 to 100 of about 8,176 (156)

Pharmaceutical quality and cost-effectiveness of branded versus generic medicines across 22 drug types and 8 therapeutic categories: a citizen-funded comparative study from regulated retail outlets in Kerala, India. [PDF]

Front Pharmacol
Philips CA, Theruvath AH, Sreemohan A, Baby A, Jose S, Philips M, Philip T, Ramesh C.   +7 more
europepmc   +1 more source

Informed Therapeutic Microbiome Modulation for Post-Infectious Irritable Bowel Syndrome: Pilot Experience of a Microbiome Clinic. [PDF]

Nutrients
Fusco W, De Maio F, Porcari S, Severino A, Salvi D, Piccirelli S, Ferrari C, Sibilla A, Quaranta G, Masucci L, Cammarota G, Sanguinetti M, Gasbarrini A, Ianiro G.   +13 more
europepmc   +1 more source

Accurately identifying cirrhosis and its complications to create the novel statewide Indiana digital cirrhosis registry. [PDF]

Sci Rep
Desai AP, Shamseddeen H, Lembcke L, Hui SL, Nephew LD, Ghabril MS, Orman ES, Chalasani N.   +7 more
europepmc   +1 more source

Modulation of gut microFLORA with rifaximin to reduce high platelet reactivity in post-ACS patients on ticagrelor: rationale and design of the FLORA-ACS study. [PDF]

Cardiol J
Grzelakowska K, Adamski P, Kasprzak M, Michalski P, Niezgoda P, Ostrowska M, Umińska J, Ratajczak J, Strzelewicz K, Grzybowski T, Skonieczna K, Buszko K, Kubica J.   +12 more
europepmc   +1 more source

Comparative efficacy of diverse therapeutic regimens for small intestinal bacterial overgrowth: a systematic network meta-analysis. [PDF]

Ther Adv Gastroenterol
Zhang Q, Li H, Chen C, Li M, Song J, Pan S, Shen B, Huang Y.   +7 more
europepmc   +1 more source

Optimal Antibiotic Selection for the Treatment of Pouchitis After Ileal Pouch-Anal Anastomosis. [PDF]

J Inflamm Res
Bronze S, Kayal M.
europepmc   +1 more source

Diagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations. [PDF]

J Am Assoc Nurse Pract
Ladewski AM, Orleck KD, Skarbinski KF.
europepmc   +1 more source

Frequent high-level rifaximin resistance in <i>Escherichia coli</i> associated with long-term treatment of patients with liver cirrhosis: a prospective, controlled study. [PDF]

Microbiol Spectr
Boll L, Kern WV, Schuster S, Schultheiß M, Schneider C, Vavra M, Thimme R, Rieg S, Camp J.   +8 more
europepmc   +1 more source

Lactulose Versus Rifaximin Monotherapy for Hepatic Encephalopathy Prevention: A Prospective Comparative Study in Patients With Cirrhosis. [PDF]

Cureus
Asghar A, Mustafa A, Yousaf J, Hussain S, Elrefae A, Ishtiaq H, Qandeel M, Atta M, Khattak MI, Tahir A.   +9 more
europepmc   +1 more source

Gut Microbiota in Irritable Bowel Syndrome and Inflammatory Bowel Disease: Differences in Pathophysiology, Biomarkers, and Treatment Implications. [PDF]

Pharmaceuticals (Basel)
Pastras P, Aggeletopoulou I, Psalti V, Triantos C.   +3 more
europepmc   +1 more source